Company Profile
Genedrive provides the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.
The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests
Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Clopidogrel Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting
Tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests.
The company serves medical, biotechnology, and pharmaceutical industries globally. Founded in 2000 and headquartered in Manchester, the United Kingdom, the company was formerly known as Epistem Holdings Plc before rebranding in July 2016. genedrive plc has a collaboration agreement with Thermo Fisher Scientific Inc. to develop a CYP2C19 pharmacogenetic in vitro diagnostic test.